<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article 
  article-type="research-article" 
  dtd-version="1.3" 
  xml:lang="en"
  xmlns:mml="http://www.w3.org/1998/Math/MathML" 
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <processing-meta
    tagset-family="jats"
    base-tagset="publishing"
    mathml-version="2.0"
    table-model="xhtml"/>
    <front>
        <journal-meta>
            <journal-id journal-id-type="publisher-id">rpse</journal-id>
            <journal-title-group>
                <journal-title>Recent Progress in Science and Engineering</journal-title>
                <abbrev-journal-title>Recent Prog Sci Eng</abbrev-journal-title>
            </journal-title-group>
            <issn pub-type="epub">3067-4573</issn>
            <issn-l>3067-4573</issn-l>
            <publisher>
                <publisher-name>LIDSEN Publishing Inc.</publisher-name>
            </publisher>
        </journal-meta>
        <article-meta>
            <article-id pub-id-type="publisher-id">rpse-02-02-007</article-id>
            <article-id pub-id-type="doi">10.21926/rpse.2602007</article-id>
            <article-categories>
                <subj-group subj-group-type="heading">
                    <subject>Research Article</subject>
                </subj-group>
            </article-categories>
            <title-group>
                <article-title>Novel Bis-Quadridentate Pyrazolone-Based Ligands and Zinc(II) Complexes: Spectroscopic Characterization and <italic>In Vitro</italic> Anti-Malarial Activity</article-title>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author">
                    <name>
                        <surname>Sathvara</surname>
                        <given-names>Jignesh P.</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff-01"/>
                </contrib>
                <contrib contrib-type="author">
                    <name>
                        <surname>Jadeja</surname>
                        <given-names>Rajendrasinh N.</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff-01"/>
                    <xref rid="cor-01" ref-type="corresp"><sup>&#x002A;</sup></xref>
                </contrib>
                <aff id="aff-01">Department of Chemistry, Faculty of Science, The Maharaja Sayajirao University of Baroda, Vadodara 390002, India; E-Mails: <email>jsathwara96@gmail.com</email>; <email>rjadeja-chem@msubaroda.ac.in</email></aff>
            </contrib-group>
            <contrib-group>
                <contrib contrib-type="editor">
                    <name>
                        <surname>Minaev</surname>
                        <given-names>Boris F.</given-names>
                    </name>
                    <role>Academic Editor</role>
                </contrib>
            </contrib-group>
            <author-notes>
                <corresp id="cor-01"><label>&#x002A;</label>Correspondence: Rajendrasinh N. Jadeja; E-Mail: <email>rjadeja-chem@msubaroda.ac.in</email></corresp>
            </author-notes> 
            <pub-date date-type="pub" publication-format="electronic" iso-8601-date="2026-04-30">
                <day>30</day>
                <month>04</month>
                <year>2026</year>
            </pub-date> 
            <volume>2</volume>
            <issue>2</issue>
            <elocation-id>007</elocation-id>
            <history>
                <date date-type="received" iso-8601-date="2026-02-12">
                    <day>12</day>
                    <month>02</month>
                    <year>2026</year>
                </date>
                <date date-type="accepted" iso-8601-date="2026-04-22">
                    <day>22</day>
                    <month>04</month>
                    <year>2026</year>
                </date>
            </history>
            <permissions>
                <copyright-statement>&#xA9; 2026 by the authors.</copyright-statement>
                <copyright-year>2026</copyright-year>
                <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0/">
                    <license-p>This is an open access article distributed under the conditions of the Creative Commons by Attribution License, which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is correctly cited.</license-p>
                </license>      
            </permissions>
            <abstract>
                <p>A new series of bis-quadridentate ligands (L<sub>1</sub>-L<sub>3</sub>) and their corresponding zinc(II) complexes (Complex 1-3) were rationally designed, synthesized, and characterized. The ligand framework features multiple donor sites that enable stable coordination to zinc(II), yielding well-defined metal complexes. The structures of the synthesized compounds were confirmed using a combination of analytical and spectroscopic techniques. Thermal gravimetric analysis revealed that all zinc complexes exhibit exceptional thermal stability, remaining stable up to 500&#x00B0;C, indicative of robust metal&#x2013;ligand interactions. The <italic>in vitro</italic> anti-plasmodial activity of the ligands and their zinc complexes was evaluated against <italic>Plasmodium falciparum</italic> using a JSB staining-assisted microscopic method. The zinc complexes demonstrated enhanced activity relative to the free ligands, with half-maximal inhibitory concentration (IC<sub>50</sub>) values of 0.67 &#x00B5;g mL<sup>-1</sup> (1), 0.53 &#x00B5;g mL<sup>-1</sup> (2), and 0.59 &#x00B5;g mL<sup>-1</sup> (3). In contrast, the free ligands exhibited IC<sub>50</sub> values ranging from 0.69 to 0.84 &#x00B5;g mL<sup>-1</sup>.</p>
            </abstract>
            <kwd-group>
                <title>Keywords</title>
                <kwd>Zn(II) complex</kwd>
                <kwd>formyl pyrazolone</kwd>
                <kwd>multidentate ligands</kwd>
            </kwd-group>
        </article-meta>
    </front>
    <body>
        <sec sec-type="intro" id="sec-01">
            <label>1.</label>
            <title>Introduction</title>
            <p>Pyrazolone is a versatile synthon for constructing diverse molecular frameworks with applications in chemistry and materials science [<xref ref-type="bibr" rid="B-001">1</xref>]. The pyrazolone framework is found in natural alkaloids and therapeutic agents, exhibiting significant biological activities and serving as a motif in enzyme inhibitors [<xref ref-type="bibr" rid="B-002">2</xref>,<xref ref-type="bibr" rid="B-003">3</xref>,<xref ref-type="bibr" rid="B-004">4</xref>,<xref ref-type="bibr" rid="B-005">5</xref>,<xref ref-type="bibr" rid="B-006">6</xref>,<xref ref-type="bibr" rid="B-007">7</xref>,<xref ref-type="bibr" rid="B-008">8</xref>,<xref ref-type="bibr" rid="B-009">9</xref>,<xref ref-type="bibr" rid="B-010">10</xref>]. Substitution at the C4 position with donor groups enhances chelation and enables selective metal coordination.</p>
            <p>Acyl-pyrazolones act as mono- or bidentate &#x03B2;-diketone ligands, but their denticity increases when the formyl or acyl group forms an imine via Schiff base condensation. This adds a nitrogen donor, enabling N,O,O- or N,O,N,O-chelation and creating rigid multidentate frameworks that stabilize higher-nuclearity metal complexes. Schiff base metal complexes themselves have attracted extensive interest for their structural flexibility and electronic properties, contributing to single-molecule magnetism, materials science [<xref ref-type="bibr" rid="B-011">11</xref>], and catalysis [<xref ref-type="bibr" rid="B-012">12</xref>]. They also possess significant industrial relevance [<xref ref-type="bibr" rid="B-013">13</xref>], while group 12 complexes with d<sup>10</sup> configuration continue to attract attention for their stability and functional versatility [<xref ref-type="bibr" rid="B-014">14</xref>,<xref ref-type="bibr" rid="B-015">15</xref>].</p>
            <p>Within this chemistry, formyl pyrazolones are valuable as they readily form imines, linking &#x03B2;-diketone coordination chemistry with Salen/Salophen-type Schiff bases. These derivatives act as tunable ligands with strong metal-binding ability and enhanced conjugation [<xref ref-type="bibr" rid="B-016">16</xref>,<xref ref-type="bibr" rid="B-017">17</xref>], enabling stable metal chelate formation [<xref ref-type="bibr" rid="B-018">18</xref>]. When converted to Schiff bases, they generate Salen- or Salophen-type tetradentate N, O-donor frameworks [<xref ref-type="bibr" rid="B-019">19</xref>,<xref ref-type="bibr" rid="B-020">20</xref>,<xref ref-type="bibr" rid="B-021">21</xref>,<xref ref-type="bibr" rid="B-022">22</xref>]. Classic Salen/Salophen ligands, formed from salicylaldehyde and diamines, possess N<sub>2</sub>O<sub>2</sub> donor sets that yield neutral, thermally stable complexes [<xref ref-type="bibr" rid="B-023">23</xref>,<xref ref-type="bibr" rid="B-024">24</xref>]. Their rigidity and chelating strength support broad catalytic activity, including oxidation, epoxidation, hydroxylation, hydrogenation, and CO<sub>2</sub> fixation [<xref ref-type="bibr" rid="B-025">25</xref>,<xref ref-type="bibr" rid="B-026">26</xref>,<xref ref-type="bibr" rid="B-027">27</xref>,<xref ref-type="bibr" rid="B-028">28</xref>,<xref ref-type="bibr" rid="B-029">29</xref>,<xref ref-type="bibr" rid="B-030">30</xref>]. Marchetti <italic>et al.</italic> reported the synthesis of pyrazolone-based hydrazones and their Zn(II) and Cu(II) complexes, which exhibited significant biological activity against <italic>Trypanosoma brucei</italic>. Among them, the Zn(II) complex showed the highest activity and selectivity, and mechanistic studies suggested that the compounds interfere with nucleotide metabolism, possibly targeting CTP synthetase [<xref ref-type="bibr" rid="B-031">31</xref>]. Gusev <italic>et al.</italic> reported Zn(II) Schiff base complexes based on the pyrazolone ligand 4-{(E)-[(2-fluorophenyl)imino]methyl}-5-methyl-2-phenyl-2,4-dihydro-3<italic>H</italic>-pyrazol-3-one (HL), exhibiting well-defined crystal structures and solvent-dependent luminescence. The complexes showed tunable emission behavior, highlighting their photophysical significance [<xref ref-type="bibr" rid="B-032">32</xref>]. Baryshnikov <italic>et al.</italic> investigated Zn(II) complexes with 3-(pyridin-2-yl)-5-(arylideneiminophenyl)-1<italic>H</italic>-1,2,4-triazole ligands using DFT and QTAIM analysis. The study highlighted the influence of tautomeric forms on the electronic structure, stereochemistry, and luminescence properties of the complexes [<xref ref-type="bibr" rid="B-033">33</xref>]. Gusev <italic>et al.</italic> reported Zn(II) Schiff base complexes based on pyrazolone-derived azomethine ligands, exhibiting high thermal stability and strong blue photoluminescence in both solution and solid state. The luminescence was attributed to intraligand charge-transfer, as supported by TD-DFT calculations. These complexes were successfully incorporated into organic light-emitting diodes (OLEDs), yielding good brightness and efficiency. The study highlights the potential of pyrazolone-based Zn(II) complexes as promising blue-emitting materials [<xref ref-type="bibr" rid="B-034">34</xref>]. The compounds exhibit an unusual excitation-dependent emission behavior, characterized by a shift in emission color from blue to yellow with increasing excitation wavelength. Quantum chemical calculations suggest that supramolecular variations in the single-crystal architecture of the synthesized complexes play a significant role in governing this photophysical behavior, as reported for novel zinc complexes with pyridyltriazoles in the study Structure and excitation-dependent emission of novel zinc complexes with pyridyltriazoles [<xref ref-type="bibr" rid="B-035">35</xref>].</p>
            <p>Malaria remains a major global health burden. According to the World Malaria Report 2022, the 568,000 deaths reported before the COVID-19 pandemic increased to 625,000 in 2020 and slightly decreased to 619,000 in 2021. During the pandemic, an estimated 63,000 additional deaths were attributed to COVID-19-related disruptions. Moreover, 247 million cases were reported in 2021, up from 245 million in 2020 and 232 million in 2019 [<xref ref-type="bibr" rid="B-036">36</xref>,<xref ref-type="bibr" rid="B-037">37</xref>]. Plasmodium falciparum, the most virulent human malaria parasite, multiplies within red blood cells, and inadequate or delayed treatment leads to increased parasitemia and progression to severe malaria [<xref ref-type="bibr" rid="B-038">38</xref>,<xref ref-type="bibr" rid="B-039">39</xref>]. Malaria control is seriously challenged by increasing drug resistance, poor treatment compliance, and the widespread availability of falsified medicines [<xref ref-type="bibr" rid="B-040">40</xref>,<xref ref-type="bibr" rid="B-041">41</xref>]. Inside infected erythrocytes, the parasite degrades hemoglobin for growth, and its inhibition is lethal. Thus, falcipain-2, a cysteine protease active in trophozoite and schizont stages, is a key target for anti-malarial drug development [<xref ref-type="bibr" rid="B-042">42</xref>,<xref ref-type="bibr" rid="B-043">43</xref>,<xref ref-type="bibr" rid="B-044">44</xref>,<xref ref-type="bibr" rid="B-045">45</xref>,<xref ref-type="bibr" rid="B-046">46</xref>].</p>
            <p>Considering these factors, a binucleating Schiff base ligand based on a pyrazolone framework was designed. It was synthesized by condensing 3,3&#x2032;-diaminobenzidine with formyl pyrazolone, along with its Zn(II) complexes, where the diamine core provides flexibility and strong metal-binding ability [<xref ref-type="bibr" rid="B-047">47</xref>]. The rationale for employing zinc is supported by the literature, which highlights the therapeutic relevance of metal-based systems in anti-malarial research. Timothy <italic>et al.</italic> [<xref ref-type="bibr" rid="B-048">48</xref>] reported that tetraazamacrocyclic complexes exhibit metal-dependent activity, with Zn<sup>2+</sup> showing appreciable potency in the order Co &#x003C; Ni &#x003C; Cu &#x003C; Zn &#x003C; Fe &#x2264; Mn. Bagul <italic>et al.</italic> [<xref ref-type="bibr" rid="B-049">49</xref>] found that the HPPHmCB ligand shows moderate activity against chloroquine-resistant <italic>Plasmodium falciparum</italic> (IC<sub>50</sub> = 5.23 &#x00B1; 0.09 &#x00B5;M), which significantly improves upon metal coordination. The Zn(PPHmCB)<sub>2</sub> complex exhibited enhanced potency (IC<sub>50</sub> = 2.39 &#x00B1; 0.08 &#x00B5;M), supporting zinc-based complex design.</p>
        </sec>
        <sec id="sec-02">
            <label>2.</label>
            <title>Experimental Procedure</title>
            <sec id="sec-02-01">
                <label>2.1</label>
                <title>Material and Instrumentation</title>
                <p>In our earlier studies [<xref ref-type="bibr" rid="B-050">50</xref>,<xref ref-type="bibr" rid="B-051">51</xref>,<xref ref-type="bibr" rid="B-052">52</xref>], the same instruments and reagents were used for all characterization studies. DMF (Sisco Research Laboratories Pvt. Ltd.) and POCl<sub>3</sub> (Loba Chemie), were employed in the experimental work. 3,3&#x2032;-Diaminobenzidine was obtained from TCI (Tokyo Chemical Industry), Japan. Dichloromethane (DCM) was procured from Avara Chemicals. Electronic absorption spectra of all compounds were measured on an Agilent Cary-60 UV&#x2013;Vis spectrophotometer. Elemental analysis was conducted using the Elementar Excellence in Elements model, Unicube superuser V1.3.2 (065bdfa).</p>
            </sec>
            <sec id="sec-02-02">
                <label>2.2</label>
                <title>Synthetic Route of Ligands</title>
                <p>The formylated pyrazolone intermediates (1-3) were prepared according to the procedure reported in our earlier publications [<xref ref-type="bibr" rid="B-016">16</xref>,<xref ref-type="bibr" rid="B-017">17</xref>]. The purified formylated intermediates were further condensed with 3,3&#x2032;-diaminobenzidine to yield the corresponding Schiff base ligands. Specifically, the formylated compound (4 mmol) was reacted with 3,3&#x2032;-diaminobenzidine (1 mmol) in methanol under reflux for 4-5 h, resulting in the formation of quadridentate Schiff base ligands, as shown in <xref ref-type="fig" rid="F-01">Figure 1</xref>. We then cooled the reaction mixture to room temperature, filtered the solid products, washed them with cold methanol, and oven-dried them. The ligands were obtained in the form of yellow powders (85-87% yield, M.P. &#x003E;200&#x00B0;C) and characterized by FT-IR (KBr, cm<sup>-1</sup>). Attempts to record NMR spectra of the ligands were unsuccessful because the compounds displayed extremely limited solubility in various deuterated solvents, even upon heating and sonication. As a result, NMR data are not included for these ligands.</p>
                <fig id="F-01" orientation="portrait" position="float">
                    <label>Figure 1</label>
                    <caption>
                        <p>Synthetic route of Schiff base ligands. Where, L<sub>1</sub>: R<sub>1</sub> = R<sub>2</sub> = H and L<sub>2</sub>: R<sub>1</sub> = Cl, R<sub>2</sub> = H and L<sub>3</sub>: R<sub>1</sub> = H, R<sub>2</sub> = CH<sub>3</sub>. L<sub>1</sub>; Mol. wt.: 951.06 (g/mol). FT-IR: 1663 (C=O pyrazolone), 1617 (C=N). EA calcd/found for C<sub>56</sub>H<sub>46</sub>N<sub>12</sub>O<sub>4</sub>(%): C 70.72/70.30; H 4.88/4.99; N 17.67/17.51. L<sub>2</sub>; Mol. wt.: 1088.83 (g/mol). FT-IR: 1663 (C=O pyrazolone), 1624 (C=N). EA calcd/found for C<sub>56</sub>H<sub>42</sub>Cl<sub>4</sub>N<sub>12</sub>O<sub>4</sub>(%): C 61.77/61.47; H 3.89/3.80; N 15.44/15.29. L<sub>3</sub>; Mol. wt.: 1007.17 (g/mol). FT-IR: 1662 (C=O pyrazolone), 1619 (C=N). EA calcd/found for C<sub>60</sub>H<sub>54</sub>N<sub>12</sub>O<sub>4</sub>(%): C 71.55/71.79; H 5.40/5.27; N 16.69/16.58. <xref ref-type="other" rid="app-F-01">Figure S1</xref> represents the actual elemental analysis data obtained directly from the instrument.</p>
                    </caption>
                    <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Figure01.jpg"/>
                </fig>
            </sec>
            <sec id="sec-02-03">
                <label>2.3</label>
                <title>Synthetic Route of Zn(II) Complexes</title>
                <p>Complexes 1-3 were synthesized by refluxing a warm DCM solution (25 mL, 35-40&#x00B0;C) of ligand L<sub>1</sub>-L<sub>3</sub> (2 mmol) with a DCM solution (15 mL) of Zn(OAc)<sub>2</sub>&#x00B7;2H<sub>2</sub>O (4 mmol) for 4-5 h. The precipitated solid was filtered after cooling, washed with cold ethanol, and dried. The synthetic route is shown in <xref ref-type="fig" rid="F-02">Figure 2</xref>. Each complex was isolated as a yellow powder in 90-95% yield with a melting point &#x003E;200&#x00B0;C and characterized by FT-IR (KBr, cm<sup>-1</sup>) and <sup>1</sup>H NMR (400 MHz, DMSO-d<sub>6</sub>, &#x03B4;, ppm).</p>
                <fig id="F-02" orientation="portrait" position="float">
                    <label>Figure 2</label>
                    <caption>
                        <p>Synthetic route of complexes. Where, complex-1: R<sub>1</sub> = R<sub>2</sub> = H and complex-2: R<sub>1</sub> = Cl, R<sub>2</sub> = H and comlpex-3 R<sub>1</sub> = H, R<sub>2</sub> = CH<sub>3</sub>. Complex-1; EA calcd/found for C<sub>56</sub>H<sub>42</sub>N<sub>12</sub>O<sub>4</sub>Zn<sub>2</sub>(%): C 62.41/62.43; H 3.93/3.93; N 15.60/15.61. FT-IR: 1621 (C=N), 1334 (C-O pyrazolone). <sup>1</sup>H NMR: 2.38 (s, 6H, CH<sub>3</sub>), 2.42 (s, 6H, CH<sub>3</sub>),7.24-8.25 (m, 26H, Ar-H), 8.9 (s, 2H, =CH), 9.1 (s, 2H, =CH). Complex-2; EA calcd/found for C<sub>56</sub>H<sub>38</sub>Cl<sub>4</sub>N<sub>12</sub>O<sub>4</sub>Zn<sub>2</sub>(%): C 55.33/55.31; H 3.15/3.15; N 13.83/13.86. FT-IR: 1623 (C=N), 1337 (C-O pyrazolone). <sup>1</sup>H NMR: 2.39 (s, 6H, CH<sub>3</sub>), 2.43 (s, 6H, CH<sub>3</sub>), 7.24-7.26 (d, 4H, (<italic>J</italic> = 8 Hz), ArH), 7.47-7.51 (m, 4H, , ArH), 7.69-7.71 (d, 2H, (<italic>J</italic> = 8 Hz), ArH), 7.94-7.96 (d, 2H, (<italic>J</italic> = 8 Hz), ArH), 8.25-8.27 (d, 4H, ArH), 8.32 (s, 6H, ArH), 8.9 (s, 2H, =CH), 9.1 (s, 2H, =CH). Complex-3; EA calcd/found for C<sub>60</sub>H<sub>50</sub>N<sub>12</sub>O<sub>4</sub>Zn<sub>2</sub>(%): C 63.56/63.58; H 4.44/4.44; N 14.82/14.83. FT-IR: 1618 (C=N), 1333 (C-O pyrazolone). <sup>1</sup>H NMR: 2.38 (s, 12H, CH<sub>3</sub>), 2.41 (s, 12H, CH<sub>3</sub>), 7.27-7.29 (d, 8H (<italic>J</italic> = 8 Hz), Ar-H), 7.67-7.69 (d, 2H, (<italic>J</italic> = 8 Hz), ArH), 7.93-7.95 (d, 2H (<italic>J</italic> = 8 Hz), Ar-H), 8.13-8.15 (d, 8H (<italic>J </italic>= 8 Hz)), 8.24 (s, 2H Ar-H), 8.88 (s, 2H, =CH), 9.07 (s, 2H, =CH).</p>
                    </caption>
                    <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Figure02.jpg"/>
                </fig>
            </sec>
            <sec id="sec-02-04">
                <label>2.4</label>
                <title>Anti-Malarial Activity</title>
                <p><italic>In vitro</italic> anti-malarial activity against the chloroquine-sensitive <italic>Plasmodium falciparum</italic> (3D7 strain) was evaluated for all compounds at Microcare Laboratory and TRC (Surat, Gujarat). The experimental assay protocol has been described in detail in our previously published reports, and the same standardized procedure was followed in the present study [<xref ref-type="bibr" rid="B-050">50</xref>,<xref ref-type="bibr" rid="B-051">51</xref>,<xref ref-type="bibr" rid="B-052">52</xref>].</p>
            </sec>
        </sec>
        <sec id="sec-03">
            <label>3.</label>
            <title>Result and Discussion</title>
            <p>The structural and spectral features of the synthesized compounds are discussed below. The bulky and flexible ligand architecture results in low solubility in typical organic solvents.</p>
            <sec id="sec-03-01">
                <label>3.1</label>
                <title>Elemental Composition</title>
                <p>The results of elemental analysis for complexes demonstrate a high level of agreement between experimentally determined and theoretically calculated values. The measured percentages of carbon, hydrogen, and nitrogen for all three complexes closely match their computed compositions, with only minor variations. These small discrepancies can be attributed to factors such as residual moisture in the samples, slight instrumental deviations, or sample handling, all of which remain within acceptable experimental limits. Overall, the strong concordance between theoretical and experimental data supports both the successful synthesis and the high purity of the prepared complexes. Theoretical and experimental elemental analysis data for complex-1, complex-2, and complex-3 (<xref ref-type="table" rid="T-01">Table 1</xref>) and <xref ref-type="other" rid="app-F-02">Figure S2</xref> represent the actual elemental analysis data obtained directly from the instrument for the complexes. The percentage differences between the theoretical and experimental values were found to be very low, with deviations of 0.06%, 0.03%, and 0.00% for complex-1; 0.22%, 0.04%, and 0.00% for complex-2; and 0.07%, 0.03%, and 0.00% for complex-3 for N, C, and H, respectively, indicating excellent agreement between the calculated and observed values.</p>
                <table-wrap id="T-01" orientation="portrait" position="float">
                    <label>Table 1</label>
                    <caption>
                        <title>Theoretical and experimental elemental analysis data for complexes.</title>
                    </caption>
                    <table frame="hsides" rules="none">
                        <thead>
                            <tr>
                                <td align="left" valign="middle" rowspan="2">Code</td>
                                <td align="left" valign="middle" colspan="3">Theoretical</td>
                                <td align="left" valign="middle" colspan="3">Practical</td>
                            </tr>
                            <tr>
                                <td align="left" valign="middle">N [%]</td>
                                <td align="left" valign="middle">C [%]</td>
                                <td align="left" valign="middle">H [%]</td>
                                <td align="left" valign="middle">N [%]</td>
                                <td align="left" valign="middle">C [%]</td>
                                <td align="left" valign="middle">H [%]</td>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td align="left" valign="middle">Complex-1</td>
                                <td align="left" valign="middle">15.60</td>
                                <td align="left" valign="middle">62.41</td>
                                <td align="left" valign="middle">3.93</td>
                                <td align="left" valign="middle">15.61</td>
                                <td align="left" valign="middle">62.43</td>
                                <td align="left" valign="middle">3.93</td>
                            </tr>
                            <tr>
                                <td align="left" valign="middle">Complex-2</td>
                                <td align="left" valign="middle">13.83</td>
                                <td align="left" valign="middle">55.33</td>
                                <td align="left" valign="middle">3.15</td>
                                <td align="left" valign="middle">13.86</td>
                                <td align="left" valign="middle">55.31</td>
                                <td align="left" valign="middle">3.15</td>
                            </tr>
                            <tr>
                                <td align="left" valign="middle">Complex-3</td>
                                <td align="left" valign="middle">14.82</td>
                                <td align="left" valign="middle">63.56</td>
                                <td align="left" valign="middle">4.44</td>
                                <td align="left" valign="middle">14.83</td>
                                <td align="left" valign="middle">63.58</td>
                                <td align="left" valign="middle">4.44</td>
                            </tr>
                        </tbody>
                    </table>  
                </table-wrap>
            </sec>
            <sec id="sec-03-02">
                <label>3.2</label>
                <title>NMR Interpretation</title>
                <p>Proton NMR studies on all zinc(II) complexes (measured in DMSO-d<sub>6</sub>) exhibit sharp, well-resolved signals that align closely with the anticipated coordination geometry and the aromatic architecture of the ligands. Due to inadequate dissolution in conventional NMR solvents, the <sup>1</sup>H NMR spectra of the free ligands are not reported. The ligands were insoluble in common organic solvents such as methanol, ethanol, chloroform, and acetone, but were slightly soluble in DMSO and DMF. Complex-1 shows two singlets at &#x03B4; 2.38 and 2.42 ppm (each integrating for 6H), attributed to the methyl groups of the pyrazolone units. The aromatic region appears as a broad multiplet between &#x03B4; 7.24-8.25 ppm (26H, Ar-H). The azomethine protons (&#x2013;CH=N&#x2013;) resonate distinctly as singlets at &#x03B4; 8.89 and 9.09 ppm (2H each), confirming coordination through the imine nitrogen [<xref ref-type="bibr" rid="B-053">53</xref>]. Complex-2 exhibits similar features with singlets at &#x03B4; 2.39 and 2.43 ppm (6H each, CH<sub>3</sub>). The aromatic protons appear as well-defined doublets and multiplets in the region &#x03B4; 7.24-8.32 ppm, including characteristic doublets at &#x03B4; 7.24-7.26 (d, 4H, <italic>J</italic> = 8 Hz), 7.47-7.51 (m, 4H), 7.69-7.71 (d, 2H, <italic>J</italic> = 8 Hz), 7.94-7.96 (d, 2H, <italic>J</italic> = 8 Hz), followed by additional downfield aromatic signals at &#x03B4; 8.25-8.27 (d, 4H, Ar-H) and 8.32 (s, 6H, Ar-H), indicating para-substituted phenyl environments. The azomethine signals remain as sharp singlets at &#x03B4; 8.87 and 9.06 ppm. Complex-3 displays two strong singlets at &#x03B4; 2.38 and 2.41 ppm (12H each), consistent with additional methyl substituents. Its aromatic region spans &#x03B4; 7.27-8.24 ppm, including characteristic doublets at &#x03B4; 7.27-7.29, 7.67-7.69, 7.93-7.95, and 8.13-8.15 ppm (<italic>J</italic> = 8 Hz), and a singlet at &#x03B4; 8.24 ppm (2H, Ar-H). The azomethine protons appear downfield as singlets at &#x03B4; 8.88 and 9.07 ppm, similar to the previous complexes. All experimental spectra can be found in <xref ref-type="other" rid="app-F-03">Figure S3</xref>, <xref ref-type="other" rid="app-F-04">Figure S4</xref>, and <xref ref-type="other" rid="app-F-05">Figure S5</xref>.</p>
            </sec>
            <sec id="sec-03-03">
                <label>3.3</label>
                <title>FT-IR Spectral Interpretation</title>
                <p>Infrared spectral studies of the ligands and their complexes clearly indicate successful metal&#x2013;ligand coordination, providing convincing evidence of complex formation. The free ligands L<sub>1</sub>-L<sub>3</sub> exhibit a characteristic carbonyl stretching band &#x03BD;(C=O) at 1662-1663 cm<sup>-1</sup>, along with azomethine &#x03BD;(C=N) vibrations in the range 1617-1624 cm<sup>-1</sup>. Following ligand-metal binding, the &#x03BD;(C=O) band disappears completely in all complexes, indicating enolization of the pyrazolone unit followed by coordination to Zn(II) through the enolate O-atom. A new absorption band appears in the region 1333-1337 cm<sup>-1</sup> in all complexes, corresponding to the &#x03BD;(C&#x2013;O) stretching of the coordinated enolate group, further confirming metal&#x2013;oxygen bond formation [<xref ref-type="bibr" rid="B-053">53</xref>]. Additionally, the azomethine stretching frequency &#x03BD;(C=N) shifts slightly to lower wavenumbers (1618-1623 cm<sup>-1</sup>) in complexes 1-3 compared to their parent ligands, which is consistent with Zn(II)&#x2013;N(imine) bond formation. Overall, the combined disappearance of the C=O band, the occurrence of the new C&#x2013;O band, and the shift in the C=N stretching frequency unequivocally Validate the formation of the Zn(II) complexes. The broad band in the region 3437-3423 cm<sup>-1 </sup>is weak and poorly defined in the free ligands but becomes more prominent in the corresponding complexes, which may be attributed to O&#x2013;H/N&#x2013;H stretching vibrations associated with intermolecular hydrogen bonding or adsorbed moisture rather than coordinated or lattice solvent molecules, as supported by TGA analysis. New bands in the regions 559-561 cm<sup>-1</sup> and 446-447 cm<sup>-1</sup> are assigned to &#x03BD;(Zn&#x2013;O) and &#x03BD;(Zn&#x2013;N), respectively. The spectra of all compounds are presented in <xref ref-type="other" rid="app-F-06">Figures S6</xref>-<xref ref-type="other" rid="app-F-11">S11</xref>. <xref ref-type="table" rid="T-02">Table 2</xref> presents a comparison of the FT-IR frequencies of ligands with complexes.</p>
                <table-wrap id="T-02" orientation="portrait" position="float">
                    <label>Table 2</label>
                    <caption>
                        <title>Comparison of FT-IR frequencies of ligands with complexes.</title>
                    </caption>
                    <table frame="hsides" rules="none">
                        <thead>
                            <tr>
                                <td align="left" valign="middle">Compound</td>
                                <td align="left" valign="middle">&#x03BD;(O&#x2013;H/N&#x2013;H)</td>
                                <td align="left" valign="middle">&#x03BD;(C=O)</td>
                                <td align="left" valign="middle">&#x03BD;(C=N)</td>
                                <td align="left" valign="middle">&#x03BD;(C&#x2013;O)</td>
                                <td align="left" valign="middle">&#x03BD;(Zn&#x2013;O)</td>
                                <td align="left" valign="middle">&#x03BD;(Zn&#x2013;N)</td>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td align="left" valign="middle">L<sub>1</sub></td>
                                <td align="left" valign="middle">3437</td>
                                <td align="left" valign="middle">1663</td>
                                <td align="left" valign="middle">1617</td>
                                <td align="left" valign="middle">-</td>
                                <td align="left" valign="middle">-</td>
                                <td align="left" valign="middle">-</td>
                            </tr>
                            <tr>
                                <td align="left" valign="middle">Complex-1</td>
                                <td align="left" valign="middle">3426</td>
                                <td align="left" valign="middle">-</td>
                                <td align="left" valign="middle">1621</td>
                                <td align="left" valign="middle">1334</td>
                                <td align="left" valign="middle">560</td>
                                <td align="left" valign="middle">446</td>
                            </tr>
                            <tr>
                                <td align="left" valign="middle">L<sub>2</sub></td>
                                <td align="left" valign="middle">3425</td>
                                <td align="left" valign="middle">1663</td>
                                <td align="left" valign="middle">1624</td>
                                <td align="left" valign="middle">-</td>
                                <td align="left" valign="middle">-</td>
                                <td align="left" valign="middle">-</td>
                            </tr>
                            <tr>
                                <td align="left" valign="middle">Complex-2</td>
                                <td align="left" valign="middle">3428</td>
                                <td align="left" valign="middle">-</td>
                                <td align="left" valign="middle">1623</td>
                                <td align="left" valign="middle">1337</td>
                                <td align="left" valign="middle">559</td>
                                <td align="left" valign="middle">447</td>
                            </tr>
                            <tr>
                                <td align="left" valign="middle">L<sub>3</sub></td>
                                <td align="left" valign="middle">3423</td>
                                <td align="left" valign="middle">1662</td>
                                <td align="left" valign="middle">1619</td>
                                <td align="left" valign="middle">-</td>
                                <td align="left" valign="middle">-</td>
                                <td align="left" valign="middle">-</td>
                            </tr>
                            <tr>
                                <td align="left" valign="middle">Complex-3</td>
                                <td align="left" valign="middle">3437</td>
                                <td align="left" valign="middle">-</td>
                                <td align="left" valign="middle">1618</td>
                                <td align="left" valign="middle">1333</td>
                                <td align="left" valign="middle">561</td>
                                <td align="left" valign="middle">447</td>
                            </tr>
                        </tbody>
                    </table> 
                </table-wrap>
            </sec>
            <sec id="sec-03-04">
                <label>3.4</label>
                <title>UV-Visible Spectra Analysis</title>
                <p>The electronic spectra of the ligands exhibit multiple bands within the 300-400 nm region, which can be ascribed to intraligand &#x03C0; &#x2192; &#x03C0;* and n &#x2192; &#x03C0;* transitions arising from the aromatic rings and azomethine functionalities (<xref ref-type="fig" rid="F-03">Figure 3</xref>). The L<sub>2</sub> spectrum exhibits a clear vibrational progression in the 374-475 nm region, indicating strong vibronic coupling in the excited state. The presence of multiple resolved peaks suggests that the electronic transition is accompanied by excitation of specific vibrational modes, likely due to a significant change in equilibrium geometry between the ground and excited states. This structured band contrasts with the broader, less resolved features in the other spectra and suggests a more rigid or well-defined chromophore environment for L<sub>2</sub>. Upon coordination with Zn(II), notable changes are observed in the spectral profiles of the complexes. All zinc(II) complexes display an absorption band around ~300 nm and ~350 nm, corresponding primarily to retained intraligand transitions within the phenyl and heterocyclic moieties. A relatively sharp band appearing in the 400-450 nm region is significantly more pronounced in the complexes. It is indicative of ligand-to-metal electronic interaction or enhanced &#x03C0;-conjugation resulting from coordination-induced electron delocalization [<xref ref-type="bibr" rid="B-054">54</xref>,<xref ref-type="bibr" rid="B-055">55</xref>]. Relative to the corresponding free ligands, the complexes show distinct red shifts (bathochromic shifts) in both major absorption bands. These shifts reflect a lowering of the energy gap between the HOMO and LUMO levels [<xref ref-type="bibr" rid="B-053">53</xref>,<xref ref-type="bibr" rid="B-056">56</xref>], which is commonly observed when ligands coordinate to metal centers, forming more rigid, conjugated frameworks. Overall, the UV&#x2013;Vis results confirm the formation of complexes and highlight the modifications in the electronic structure upon metal coordination.</p>
                <fig id="F-03" orientation="portrait" position="float">
                    <label>Figure 3</label>
                    <caption>
                        <p>UV-Vis spectra of ligands and Zn(II) complexes.</p>
                    </caption>
                    <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Figure03.jpg"/>
                </fig>
            </sec>
            <sec id="sec-03-05">
                <label>3.5</label>
                <title>TGA Analysis</title>
                <p>The thermogravimetric analysis (TGA) curves of the complexes (<xref ref-type="other" rid="app-F-11">Figure S11</xref>, <xref ref-type="other" rid="app-F-12">Figure S12</xref>, and <xref ref-type="other" rid="app-F-13">Figure S13</xref>) show that all complexes possess good thermal stability. Complex 1 shows a very small, gradual weight loss of about 4.35% at lower temperatures, which can be assigned to the loss of physisorbed water or minor surface effects rather than the loss of coordinated solvent or water molecules. No clear mass-loss step related to volatile components is observed. Complex 2 exhibits a gradual mass loss up to approximately 500&#x00B0;C. Beyond this temperature, a sharp weight loss of about 34.9% is observed, indicating the temperature at which significant decomposition of the organic ligand framework begins. Similarly, complex 3 remains stable up to around 500&#x00B0;C, after which a major weight loss (~45.48%) occurs, corresponding to the temperature at which breakdown of the coordinated ligand structure starts.</p>
                <p>The fact that major decomposition begins only at high temperatures for all complexes confirms strong metal-ligand bonding and good thermal stability. <xref ref-type="other" rid="app-F-12">Figure S12</xref>, <xref ref-type="other" rid="app-F-13">Figure S13</xref>, and <xref ref-type="other" rid="app-F-14">Figure S14</xref> show TGA curves indicating high thermal stability of the complexes up to ~500&#x00B0;C.</p>
            </sec>
            <sec id="sec-03-06">
                <label>3.6</label>
                <title>In Vitro Anti-Malarial Activity</title>
                <p>The synthesized ligands (L<sub>1</sub>-L<sub>3</sub>) and their corresponding zinc(II) complexes were evaluated for their <italic>in vitro</italic> anti-plasmodial efficacy against the chloroquine-sensitive <italic>Plasmodium falciparum</italic> 3D7 strain via a modified Rieckmann assay. All tested compounds exhibited notable activity, with IC<sub>50 </sub>values ranging from 0.53 to 0.84 &#x00B5;M. A key observation was the significantly improved inhibitory potency of the Zn(II) complexes relative to their free ligands. For comparison, reference drugs chloroquine (CQ) [<xref ref-type="bibr" rid="B-057">57</xref>] and quinine (QN) [<xref ref-type="bibr" rid="B-058">58</xref>] gave IC<sub>50 </sub>values of 0.063 &#x00B5;M and 0.826 &#x00B5;M, respectively. While the synthesized compounds were less potent than CQ, the observed improvement in activity upon zinc coordination suggests that these metal-based scaffolds may be promising candidates for further investigation as anti-malarial agents. The complete biological data are compiled in <xref ref-type="table" rid="T-03">Table 3</xref>. The biological activity of the synthesized ligands and their three zinc(II) complexes was evaluated and compared with our previously reported study on related bidentate acylpyrazolone metal complex. A structurally related complex, [Zn<sub>2</sub>(L<sub>2</sub>C)<sub>2</sub>(HQ)<sub>2</sub>] (C<sub>52</sub>H<sub>34</sub>Cl<sub>2</sub>N<sub>8</sub>O<sub>10</sub>Zn<sub>2</sub>), has been reported to exhibit significant anti-malarial activity with an IC<sub>50</sub> value of 0.79 &#x00B5;M. The anti-malarial activity observed for the present zinc(II) complexes is promising and comparable to that reported in our earlier publication and with some of the most active zinc complexes described in the literature, as summarized in <xref ref-type="table" rid="T-03">Table 3</xref>.</p>
                <table-wrap id="T-03" orientation="portrait" position="float">
                    <label>Table 3</label>
                    <caption>
                        <title>Plasmodium inhibition by the developed compounds [&#x03BC;M].</title>
                    </caption>
                    <table frame="hsides" rules="none">
                        <thead>
                            <tr>
                                <td align="left" valign="middle">Sr. No.</td>
                                <td align="left" valign="middle">Complex/Ligand</td>
                                <td align="left" valign="middle">
                                    <p><italic>Plasmodium falciparum</italic></p>
                                    <p>Mean IC<sub>50</sub><sup>a</sup></p>
                                </td>
                                <td align="left" valign="middle">Reference</td>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td align="left" valign="middle">1</td>
                                <td align="left" valign="middle">Chloroquine</td>
                                <td align="left" valign="middle">0.063</td>
                                <td align="left" valign="middle" rowspan="2">[<xref ref-type="bibr" rid="B-057">57</xref>,<xref ref-type="bibr" rid="B-058">58</xref>]</td>
                            </tr>
                            <tr>
                                <td align="left" valign="middle">2</td>
                                <td align="left" valign="middle">Quinine</td>
                                <td align="left" valign="middle">0.826</td>
                            </tr>
                            <tr>
                                <td align="left" valign="middle" rowspan="6">3</td>
                                <td align="left" valign="middle">L<sub>1</sub></td>
                                <td align="left" valign="middle">0.69</td>
                                <td align="left" valign="middle" rowspan="6">Present study</td>
                            </tr>
                            <tr>
                                <td align="left" valign="middle">Complex-1</td>
                                <td align="left" valign="middle">0.67</td>
                            </tr>
                            <tr>
                                <td align="left" valign="middle">L<sub>2</sub></td>
                                <td align="left" valign="middle">0.84</td>
                            </tr>
                            <tr>
                                <td align="left" valign="middle">Complex-2</td>
                                <td align="left" valign="middle">0.53</td>
                            </tr>
                            <tr>
                                <td align="left" valign="middle">L<sub>3</sub></td>
                                <td align="left" valign="middle">0.73</td>
                            </tr>
                            <tr>
                                <td align="left" valign="middle">Complex-3</td>
                                <td align="left" valign="middle">0.59</td>
                            </tr>
                            <tr>
                                <td align="left" valign="middle">4</td>
                                <td align="left" valign="middle">[Zn<sub>2</sub>(L<sub>2</sub>C)<sub>2</sub>(HQ)<sub>2</sub>]</td>
                                <td align="left" valign="middle">0.79</td>
                                <td align="left" valign="middle">[<xref ref-type="bibr" rid="B-050">50</xref>]</td>
                            </tr>
                        </tbody>
                    </table>
                    <table-wrap-foot>
                        <fn id="TF-03"><p><sup>a</sup>Average results of duplicate experiments.</p></fn>
                    </table-wrap-foot>  
                </table-wrap>
            </sec>
        </sec>
        <sec sec-type="conclusions" id="sec-04">
            <label>4.</label>
            <title>Conclusion</title>
            <p>A novel series of binuclear bis-quadridentate ligands and their corresponding zinc(II) complexes were successfully synthesized and characterized by elemental analysis, TGA, UV-Vis, NMR, and IR spectroscopy. Complex formation was confirmed by UV-Vis spectroscopy through the appearance of characteristic metal&#x2013;ligand charge-transfer bands. All complexes exhibited notable <italic>in vitro</italic> anti-malarial activity against <italic>Plasmodium falciparum</italic>. Compared to the free ligands, the zinc(II) complexes demonstrated enhanced biological activity, suggesting that increasing zinc coordination from mononuclear to binuclear frameworks improves anti-malarial efficacy. However, due to the bulky, rigid nature of these compounds, solubility limitations prevented further characterization.</p>
        </sec>
    </body>
    <back>
        <ack>
            <title>Acknowledgments</title>
            <p>The authors would like to acknowledge CSIR-HRDG (Council of Scientific and Industrial Research) for providing CSIR-Senior Research Fellowship to JPS. We are thankful to the Head of the Department of Chemistry at the Maharaja Sayajirao University of Baroda for offering the centres and resources required to complete this work.</p>
        </ack>
        <notes>
            <title>Author Contributions</title>
            <p>Rajendrasinh N. Jadeja: Conceptualization, reviewing and supervision for the synthesis and characterization have been done with his help. Jignesh P. Sathvara: He handled the synthesis, characterization, data analysis, and writing for the initial draft.</p>
        </notes>
        <notes>
            <title>Funding</title>
            <p>No funding information is available for this work.</p>
        </notes>
        <notes notes-type="conflict-interest">
            <title>Competing Interests</title>     
            <p>The authors emphasize that they are not aware of any personal or financial conflicts that might have appeared to affect the research described in this paper. It is unnecessary to disclose any conflicts.</p>       
        </notes>
        <sec sec-type="supplementary-files">
            <title>Additional Materials</title>
            <p>The following additional materials are uploaded at the page of this paper.</p>
            <supplementary-material id="app-F-01" mimetype="graphic" xlink:href="rpse.2602007-supplementary.pdf">
                <label>1. </label>
                <caption>
                    <p>Figure S1: The actual elemental analysis data obtained directly from the instrument.</p>
                </caption>
            </supplementary-material>
            <supplementary-material id="app-F-02" mimetype="graphic" xlink:href="rpse.2602007-supplementary.pdf">
                <label>2. </label>
                <caption>
                    <p>Figure S2: The actual elemental analysis data obtained directly from the instrument for the complexes.</p>
                </caption>
            </supplementary-material>
            <supplementary-material id="app-F-03" mimetype="graphic" xlink:href="rpse.2602007-supplementary.pdf">
                <label>3. </label>
                <caption>
                    <p>Figure S3: NMR spectrum of complex-1.</p>
                </caption>
            </supplementary-material>
            <supplementary-material id="app-F-04" mimetype="graphic" xlink:href="rpse.2602007-supplementary.pdf">
                <label>4. </label>
                <caption>
                    <p>Figure S4: NMR spectrum of complex-2.</p>
                </caption>
            </supplementary-material>
            <supplementary-material id="app-F-05" mimetype="graphic" xlink:href="rpse.2602007-supplementary.pdf">
                <label>5. </label>
                <caption>
                    <p>Figure S5: NMR spectrum of complex-3.</p>
                </caption>
            </supplementary-material>
            <supplementary-material id="app-F-06" mimetype="graphic" xlink:href="rpse.2602007-supplementary.pdf">
                <label>6. </label>
                <caption>
                    <p>Figure S6: FT-IR spectrum of L<sub>1</sub>.</p>
                </caption>
            </supplementary-material>
            <supplementary-material id="app-F-07" mimetype="graphic" xlink:href="rpse.2602007-supplementary.pdf">
                <label>7. </label>
                <caption>
                    <p>Figure S7: FT-IR spectrum of L<sub>2</sub>.</p>
                </caption>
            </supplementary-material>
            <supplementary-material id="app-F-08" mimetype="graphic" xlink:href="rpse.2602007-supplementary.pdf">
                <label>8. </label>
                <caption>
                    <p>Figure S8: FT-IR spectrum of L<sub>3</sub>.</p>
                </caption>
            </supplementary-material>
            <supplementary-material id="app-F-09" mimetype="graphic" xlink:href="rpse.2602007-supplementary.pdf">
                <label>9. </label>
                <caption>
                    <p>Figure S9: FT-IR spectrum of complex-1.</p>
                </caption>
            </supplementary-material>
            <supplementary-material id="app-F-10" mimetype="graphic" xlink:href="rpse.2602007-supplementary.pdf">
                <label>10. </label>
                <caption>
                    <p>Figure S10: FT-IR spectrum of complex-2.</p>
                </caption>
            </supplementary-material>
            <supplementary-material id="app-F-11" mimetype="graphic" xlink:href="rpse.2602007-supplementary.pdf">
                <label>11. </label>
                <caption>
                    <p>Figure S11: FT-IR spectrum of complex-3.</p>
                </caption>
            </supplementary-material>
            <supplementary-material id="app-F-12" mimetype="graphic" xlink:href="rpse.2602007-supplementary.pdf">
                <label>12. </label>
                <caption>
                    <p>Figure S12: TGA curve of the synthesized complex-1.</p>
                </caption>
            </supplementary-material>
            <supplementary-material id="app-F-13" mimetype="graphic" xlink:href="rpse.2602007-supplementary.pdf">
                <label>13. </label>
                <caption>
                    <p>Figure S13: TGA curve of the synthesized complex-2.</p>
                </caption>
            </supplementary-material>
            <supplementary-material id="app-F-14" mimetype="graphic" xlink:href="rpse.2602007-supplementary.pdf">
                <label>14. </label>
                <caption>
                    <p>Figure S14: TGA curve of the synthesized complex-3.</p>
                </caption>
            </supplementary-material>
        </sec>
        <ref-list>
            <title>References</title>
            <ref id="B-001">
                <label>1. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Fustero</surname><given-names>S</given-names></name>,
                <name><surname>Sanchez-Rosello</surname><given-names>M</given-names></name>,
                <name><surname>Barrio</surname><given-names>P</given-names></name>,
                <name><surname>Simon-Fuentes</surname><given-names>A</given-names></name>.
                <article-title>From 2000 to mid-2010: A fruitful decade for the synthesis of pyrazoles</article-title>.
                <source>Chem Rev</source>.
                <year iso-8601-date="2011">2011</year>; 
                <volume>111</volume>: 
                <fpage>6984</fpage>-<lpage>7034</lpage>.
                </mixed-citation>
            </ref>
            <ref id="B-002">
                <label>2. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Liu</surname><given-names>S</given-names></name>,
                <name><surname>Bao</surname><given-names>X</given-names></name>,
                <name><surname>Wang</surname><given-names>B</given-names></name>.
                <article-title>Pyrazolone: A powerful synthon for asymmetric diverse derivatizations</article-title>.
                <source>Chem Commun</source>.
                <year iso-8601-date="2018">2018</year>; 
                <volume>54</volume>: 
                <fpage>11515</fpage>-<lpage>11529</lpage>.
                </mixed-citation>
            </ref>
            <ref id="B-003">
                <label>3. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Yu</surname><given-names>F</given-names></name>,
                <name><surname>Chen</surname><given-names>Z</given-names></name>,
                <name><surname>Hao</surname><given-names>X</given-names></name>,
                <name><surname>Jiang</surname><given-names>X</given-names></name>,
                <name><surname>Yan</surname><given-names>S</given-names></name>,
                <name><surname>Lin</surname><given-names>J</given-names></name>.
                <article-title>Three component solvent-free synthesis of 1<italic>H</italic>-pyrazol-5(4<italic>H</italic>)-one-based heterocyclic ketene aminal derivatives</article-title>.
                <source>RSC Adv</source>.
                <year iso-8601-date="2013">2013</year>; 
                <volume>3</volume>: 
                <fpage>13183</fpage>-<lpage>13192</lpage>.
                </mixed-citation>
            </ref>
            <ref id="B-004">
                <label>4. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Liu</surname><given-names>L</given-names></name>,
                <name><surname>Norman</surname><given-names>MH</given-names></name>,
                <name><surname>Lee</surname><given-names>M</given-names></name>,
                <name><surname>Xi</surname><given-names>N</given-names></name>,
                <name><surname>Siegmund</surname><given-names>A</given-names></name>,
                <name><surname>Boezio</surname><given-names>AA</given-names></name>,
                <etal/>.
                <article-title>Structure-based design of novel class II c-Met inhibitors: 2. SAR and kinase selectivity profiles of the pyrazolone series</article-title>.
                <source>J Med Chem</source>.
                <year iso-8601-date="2012">2012</year>; 
                <volume>55</volume>: 
                <fpage>1868</fpage>-<lpage>1897</lpage>.
                </mixed-citation>
            </ref>
            <ref id="B-005">
                <label>5. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Takahashi</surname><given-names>T</given-names></name>,
                <name><surname>Nagase</surname><given-names>T</given-names></name>,
                <name><surname>Sasaki</surname><given-names>T</given-names></name>,
                <name><surname>Nagumo</surname><given-names>A</given-names></name>,
                <name><surname>Shimamura</surname><given-names>K</given-names></name>,
                <name><surname>Miyamoto</surname><given-names>Y</given-names></name>,
                <etal/>.
                <article-title>Synthesis and evaluation of a novel indoledione class of long chain fatty acid elongase 6 (ELOVL6) inhibitors</article-title>.
                <source>J Med Chem</source>.
                <year iso-8601-date="2009">2009</year>; 
                <volume>52</volume>: 
                <fpage>3142</fpage>-<lpage>3145</lpage>.
                </mixed-citation>
            </ref>
            <ref id="B-006">
                <label>6. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Duffy</surname><given-names>KJ</given-names></name>,
                <name><surname>Darcy</surname><given-names>MG</given-names></name>,
                <name><surname>Delorme</surname><given-names>E</given-names></name>,
                <name><surname>Dillon</surname><given-names>SB</given-names></name>,
                <name><surname>Eppley</surname><given-names>DF</given-names></name>,
                <name><surname>Erickson-Miller</surname><given-names>C</given-names></name>,
                <etal/>.
                <article-title>Hydrazinonaphthalene and azonaphthalene thrombopoietin mimics are nonpeptidyl promoters of megakaryocytopoiesis</article-title>.
                <source>J Med Chem</source>.
                <year iso-8601-date="2001">2001</year>; 
                <volume>44</volume>: 
                <fpage>3730</fpage>-<lpage>3745</lpage>.
                </mixed-citation>
            </ref>
            <ref id="B-007">
                <label>7. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Chiba</surname><given-names>P</given-names></name>,
                <name><surname>Holzer</surname><given-names>W</given-names></name>,
                <name><surname>Landau</surname><given-names>M</given-names></name>,
                <name><surname>Bechmann</surname><given-names>G</given-names></name>,
                <name><surname>Lorenz</surname><given-names>K</given-names></name>,
                <name><surname>Plagens</surname><given-names>B</given-names></name>,
                <etal/>.
                <article-title>Substituted 4-acylpyrazoles and 4-acylpyrazolones: Synthesis and multidrug resistance-modulating activity</article-title>.
                <source>J Med Chem</source>.
                <year iso-8601-date="1998">1998</year>; 
                <volume>41</volume>: 
                <fpage>4001</fpage>-<lpage>4011</lpage>.
                </mixed-citation>
            </ref>
            <ref id="B-008">
                <label>8. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Kees</surname><given-names>KL</given-names></name>,
                <name><surname>Fitzgerald</surname><given-names>JJ</given-names></name>,
                <name><surname>Steiner</surname><given-names>KE</given-names></name>,
                <name><surname>Mattes</surname><given-names>JF</given-names></name>,
                <name><surname>Mihan</surname><given-names>B</given-names></name>,
                <name><surname>Tosi</surname><given-names>T</given-names></name>,
                <etal/>.
                <article-title>New potent antihyperglycemic agents in db/db mice: Synthesis and structure&#x2013; activity relationship studies of (4-substituted benzyl)(trifluoromethyl) pyrazoles and-pyrazolones</article-title>.
                <source>J Med Chem</source>.
                <year iso-8601-date="1996">1996</year>; 
                <volume>39</volume>: 
                <fpage>3920</fpage>-<lpage>3928</lpage>.
                </mixed-citation>
            </ref>
            <ref id="B-009">
                <label>9. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Arnost</surname><given-names>M</given-names></name>,
                <name><surname>Pierce</surname><given-names>A</given-names></name>,
                <name><surname>ter Haar</surname><given-names>E</given-names></name>,
                <name><surname>Lauffer</surname><given-names>D</given-names></name>,
                <name><surname>Madden</surname><given-names>J</given-names></name>,
                <name><surname>Tanner</surname><given-names>K</given-names></name>,
                <etal/>.
                <article-title>3-Aryl-4-(arylhydrazono)-1<italic>H</italic>-pyrazol-5-ones: Highly ligand efficient and potent inhibitors of GSK3&#x03B2;</article-title>.
                <source>Bioorg Med Chem Lett</source>.
                <year iso-8601-date="2010">2010</year>; 
                <volume>20</volume>: 
                <fpage>1661</fpage>-<lpage>1664</lpage>.
                </mixed-citation>
            </ref>
            <ref id="B-010">
                <label>10. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Marchetti</surname><given-names>F</given-names></name>,
                <name><surname>Pettinari</surname><given-names>C</given-names></name>,
                <name><surname>Di Nicola</surname><given-names>C</given-names></name>,
                <name><surname>Tombesi</surname><given-names>A</given-names></name>,
                <name><surname>Pettinari</surname><given-names>R</given-names></name>.
                <article-title>Coordination chemistry of pyrazolone-based ligands and applications of their metal complexes</article-title>.
                <source>Coord Chem Rev</source>.
                <year iso-8601-date="2019">2019</year>; 
                <volume>401</volume>: 
                <fpage>213069</fpage>.
                </mixed-citation>
            </ref>
            <ref id="B-011">
                <label>11. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Khan</surname><given-names>MT</given-names></name>,
                <name><surname>Halligudi</surname><given-names>SB</given-names></name>,
                <name><surname>Shukla</surname><given-names>S</given-names></name>,
                <name><surname>Shaikh</surname><given-names>ZA</given-names></name>.
                <article-title>Reductive carbonylation of nitrobenzene to phenylurethane catalyzed by Ru(III)-schiff base complexes</article-title>.
                <source>J Mol Catal</source>.
                <year iso-8601-date="1990">1990</year>; 
                <volume>57</volume>: 
                <fpage>301</fpage>-<lpage>305</lpage>.
                </mixed-citation>
            </ref>
            <ref id="B-012">
                <label>12. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Bose</surname><given-names>D</given-names></name>,
                <name><surname>Banerjee</surname><given-names>J</given-names></name>,
                <name><surname>Rahaman</surname><given-names>SH</given-names></name>,
                <name><surname>Mostafa</surname><given-names>G</given-names></name>,
                <name><surname>Fun</surname><given-names>HK</given-names></name>,
                <name><surname>Walsh</surname><given-names>RD</given-names></name>,
                <etal/>.
                <article-title>Polymeric end-to-end bibridged cadmium(II)thiocyanates containing monodentate and bidentate N-donor organic blockers: Supramolecular synthons based on &#x03C0;&#x2013;&#x03C0; and/or C&#x2013;H&#x00B7;&#x00B7;&#x00B7;&#x03C0; interactions</article-title>.
                <source>Polyhedron</source>.
                <year iso-8601-date="2004">2004</year>; 
                <volume>23</volume>: 
                <fpage>2045</fpage>-<lpage>2053</lpage>.
                </mixed-citation>
            </ref>
            <ref id="B-013">
                <label>13. </label>
                <mixed-citation publication-type="journal">
                <name><surname>El-Boraey</surname><given-names>HA</given-names></name>.
                <article-title>Structural and thermal studies of some aroylhydrazone Schiff&#x2019;s bases-transition metal complexes</article-title>.
                <source>J Therm Anal Calorim</source>.
                <year iso-8601-date="2005">2005</year>; 
                <volume>81</volume>: 
                <fpage>339</fpage>-<lpage>346</lpage>.
                </mixed-citation>
            </ref>
            <ref id="B-014">
                <label>14. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Singh</surname><given-names>BK</given-names></name>,
                <name><surname>Mishra</surname><given-names>P</given-names></name>,
                <name><surname>Garg</surname><given-names>BS</given-names></name>.
                <article-title>Synthesis and spectrothermal studies on group 12 metals coordination with novel carboxyamide ligands</article-title>.
                <source>Spectrochim Acta A</source>.
                <year iso-8601-date="2008">2008</year>; 
                <volume>69</volume>: 
                <fpage>361</fpage>-<lpage>370</lpage>.
                </mixed-citation>
            </ref>
            <ref id="B-015">
                <label>15. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Swamy</surname><given-names>SJ</given-names></name>,
                <name><surname>Pola</surname><given-names>S</given-names></name>.
                <article-title>Spectroscopic studies on Co(II), Ni(II), Cu(II) and Zn(II) complexes with a N4-macrocylic ligands</article-title>.
                <source>Spectrochim Acta A</source>.
                <year iso-8601-date="2008">2008</year>; 
                <volume>70</volume>: 
                <fpage>929</fpage>-<lpage>933</lpage>.
                </mixed-citation>
            </ref>
            <ref id="B-016">
                <label>16. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Thaker</surname><given-names>BT</given-names></name>,
                <name><surname>Surati</surname><given-names>KR</given-names></name>,
                <name><surname>Oswal</surname><given-names>S</given-names></name>,
                <name><surname>Jadeja</surname><given-names>RN</given-names></name>,
                <name><surname>Gupta</surname><given-names>VK</given-names></name>.
                <article-title>Synthesis, spectral, thermal and crystallographic investigations on oxovanadium(IV) and manganese(III) complexes derived from heterocyclic &#x03B2;-diketone and 2-amino ethanol</article-title>.
                <source>Struct Chem</source>.
                <year iso-8601-date="2007">2007</year>; 
                <volume>18</volume>: 
                <fpage>295</fpage>-<lpage>310</lpage>.
                </mixed-citation>
            </ref>
            <ref id="B-017">
                <label>17. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Solanki</surname><given-names>J</given-names></name>,
                <name><surname>Surati</surname><given-names>K</given-names></name>.
                <article-title>Heteroleptic Zn(II) complexes: Synthesis, characterization and photoluminescence properties</article-title>.
                <source>J Fluoresc</source>.
                <year iso-8601-date="2019">2019</year>; 
                <volume>29</volume>: 
                <fpage>865</fpage>-<lpage>875</lpage>.
                </mixed-citation>
            </ref>
            <ref id="B-018">
                <label>18. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Burlov</surname><given-names>AS</given-names></name>,
                <name><surname>Koshchienko</surname><given-names>YV</given-names></name>,
                <name><surname>Makarova</surname><given-names>NI</given-names></name>,
                <name><surname>Kuz&#x2019;menko</surname><given-names>TY</given-names></name>,
                <name><surname>Chesnokov</surname><given-names>VV</given-names></name>,
                <name><surname>Kiskin</surname><given-names>MA</given-names></name>,
                <etal/>.
                <article-title>Mixed-ligand Zn(II) complexes of 1-phenyl-3-methyl-4-formylpyrazole-5-one and various aminoheterocycles: Synthesis, structure and photoluminescence properties</article-title>.
                <source>Synth Met</source>.
                <year iso-8601-date="2016">2016</year>; 
                <volume>220</volume>: 
                <fpage>543</fpage>-<lpage>550</lpage>.
                </mixed-citation>
            </ref>
            <ref id="B-019">
                <label>19. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Gusev</surname><given-names>A</given-names></name>,
                <name><surname>Shul&#x2019;gin</surname><given-names>V</given-names></name>,
                <name><surname>Braga</surname><given-names>E</given-names></name>,
                <name><surname>Zamnius</surname><given-names>E</given-names></name>,
                <name><surname>Starova</surname><given-names>G</given-names></name>,
                <name><surname>Lyssenko</surname><given-names>K</given-names></name>,
                <etal/>.
                <article-title>Luminescent properties of zinc complexes of 4-formylpyrazolone based azomethine ligands: Excitation-dependent emission in solution</article-title>.
                <source>J Lumin</source>.
                <year iso-8601-date="2018">2018</year>; 
                <volume>202</volume>: 
                <fpage>370</fpage>-<lpage>376</lpage>.
                </mixed-citation>
            </ref>
            <ref id="B-020">
                <label>20. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Gusev</surname><given-names>AN</given-names></name>,
                <name><surname>Kiskin</surname><given-names>MA</given-names></name>,
                <name><surname>Braga</surname><given-names>EV</given-names></name>,
                <name><surname>Chapran</surname><given-names>M</given-names></name>,
                <name><surname>Wiosna-Salyga</surname><given-names>G</given-names></name>,
                <name><surname>Baryshnikov</surname><given-names>GV</given-names></name>,
                <etal/>.
                <article-title>Novel zinc complex with an ethylenediamine Schiff base for high-luminance blue fluorescent OLED applications</article-title>.
                <source>J Phys Chem C</source>.
                <year iso-8601-date="2019">2019</year>; 
                <volume>123</volume>: 
                <fpage>11850</fpage>-<lpage>11859</lpage>.
                </mixed-citation>
            </ref>
            <ref id="B-021">
                <label>21. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Fallah-Mehrjardi</surname><given-names>M</given-names></name>,
                <name><surname>Kargar</surname><given-names>H</given-names></name>,
                <name><surname>Munawar</surname><given-names>KS</given-names></name>,
                <name><surname>Ashfaq</surname><given-names>M</given-names></name>.
                <article-title>Metal complexes incorporating tetradentate ONNO Schiff base ligands: Synthesis, spectral investigations, crystal structures, theoretical studies, and potential applications</article-title>.
                <source>J Mol Struct</source>.
                <year iso-8601-date="2025">2025</year>; 
                <volume>1342</volume>: 
                <fpage>142760</fpage>.
                </mixed-citation>
            </ref>
            <ref id="B-022">
                <label>22. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Kargar</surname><given-names>H</given-names></name>,
                <name><surname>Kubicki</surname><given-names>M</given-names></name>,
                <name><surname>Fallah-Mehrjardi</surname><given-names>M</given-names></name>,
                <name><surname>Abyar</surname><given-names>F</given-names></name>,
                <name><surname>Munawar</surname><given-names>KS</given-names></name>,
                <name><surname>Ashfaq</surname><given-names>M</given-names></name>.
                <article-title>Spectroscopic, structural, theoretical, and molecular docking studies of Zn(II), Cu(II), and Ni(II) complexes incorporating a symmetrical N<sub>2</sub>O<sub>2</sub> tetradentate Schiff base ligand</article-title>.
                <source>J Mol Struct</source>.
                <year iso-8601-date="2025">2025</year>; 
                <volume>1342</volume>: 
                <fpage>142797</fpage>.
                </mixed-citation>
            </ref>
            <ref id="B-023">
                <label>23. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Vigato</surname><given-names>PA</given-names></name>,
                <name><surname>Tamburini</surname><given-names>S</given-names></name>.
                <article-title>The challenge of cyclic and acyclic Schiff bases and related derivatives</article-title>.
                <source>CoordChem Rev</source>.
                <year iso-8601-date="2004">2004</year>; 
                <volume>248</volume>: 
                <fpage>1717</fpage>-<lpage>2128</lpage>.
                </mixed-citation>
            </ref>
            <ref id="B-024">
                <label>24. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Sabat&#x00E9;</surname><given-names>F</given-names></name>,
                <name><surname>Gavara</surname><given-names>R</given-names></name>,
                <name><surname>Giannicchi</surname><given-names>I</given-names></name>,
                <name><surname>Bosque</surname><given-names>R</given-names></name>,
                <name><surname>Dalla Cort</surname><given-names>A</given-names></name>,
                <name><surname>Rodr&#x00ED;guez</surname><given-names>L</given-names></name>.
                <article-title>Ternary assemblies comprising metal&#x2013;salophen complexes and 4,4&#x2019;-bipyridine</article-title>.
                <source>New J Chem</source>.
                <year iso-8601-date="2016">2016</year>; 
                <volume>40</volume>: 
                <fpage>5714</fpage>-<lpage>5721</lpage>.
                </mixed-citation>
            </ref>
            <ref id="B-025">
                <label>25. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Al Zoubi</surname><given-names>W</given-names></name>,
                <name><surname>Ko</surname><given-names>YG</given-names></name>.
                <article-title>Organometallic complexes of Schiff bases: Recent progress in oxidation catalysis</article-title>.
                <source>J Organomet Chem</source>.
                <year iso-8601-date="2016">2016</year>; 
                <volume>822</volume>: 
                <fpage>173</fpage>-<lpage>188</lpage>.
                </mixed-citation>
            </ref>
            <ref id="B-026">
                <label>26. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Johansson</surname><given-names>M</given-names></name>,
                <name><surname>Purse</surname><given-names>BW</given-names></name>,
                <name><surname>Terasaki</surname><given-names>O</given-names></name>,
                <name><surname>B&#x00E4;ckvall</surname><given-names>JE</given-names></name>.
                <article-title>Aerobic oxidations catalyzed by zeolite-encapsulated cobalt salophen</article-title>.
                <source>Adv Synth Catal</source>.
                <year iso-8601-date="2008">2008</year>; 
                <volume>350</volume>: 
                <fpage>1807</fpage>-<lpage>1815</lpage>.
                </mixed-citation>
            </ref>
            <ref id="B-027">
                <label>27. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Jiang</surname><given-names>J</given-names></name>,
                <name><surname>Ma</surname><given-names>K</given-names></name>,
                <name><surname>Zheng</surname><given-names>Y</given-names></name>,
                <name><surname>Cai</surname><given-names>S</given-names></name>,
                <name><surname>Li</surname><given-names>R</given-names></name>,
                <name><surname>Ma</surname><given-names>J</given-names></name>.
                <article-title>Cobalt salophen complex immobilized into montmorillonite as catalyst for the epoxidation of cyclohexene by air</article-title>.
                <source>Appl Clay Sci</source>.
                <year iso-8601-date="2009">2009</year>; 
                <volume>45</volume>: 
                <fpage>117</fpage>-<lpage>122</lpage>.
                </mixed-citation>
            </ref>
            <ref id="B-028">
                <label>28. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Wu</surname><given-names>F</given-names></name>,
                <name><surname>Wang</surname><given-names>CJ</given-names></name>,
                <name><surname>Lin</surname><given-names>H</given-names></name>,
                <name><surname>Jia</surname><given-names>AQ</given-names></name>,
                <name><surname>Zhang</surname><given-names>QF</given-names></name>.
                <article-title>Syntheses, structures and catalytic properties of ruthenium(II) nitrosyl complexes with bidentate and tetradentate Schiff base ligands</article-title>.
                <source>Inorg Chim Acta</source>.
                <year iso-8601-date="2018">2018</year>; 
                <volume>471</volume>: 
                <fpage>718</fpage>-<lpage>723</lpage>.
                </mixed-citation>
            </ref>
            <ref id="B-029">
                <label>29. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Castro-Osma</surname><given-names>JA</given-names></name>,
                <name><surname>Lamb</surname><given-names>KJ</given-names></name>,
                <name><surname>North</surname><given-names>M</given-names></name>.
                <article-title>Cr(salophen) complex catalyzed cyclic carbonate synthesis at ambient temperature and pressure</article-title>.
                <source>ACS Catal</source>.
                <year iso-8601-date="2016">2016</year>; 
                <volume>6</volume>: 
                <fpage>5012</fpage>-<lpage>5025</lpage>.
                </mixed-citation>
            </ref>
            <ref id="B-030">
                <label>30. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Chun</surname><given-names>J</given-names></name>,
                <name><surname>Kang</surname><given-names>S</given-names></name>,
                <name><surname>Kang</surname><given-names>N</given-names></name>,
                <name><surname>Lee</surname><given-names>SM</given-names></name>,
                <name><surname>Kim</surname><given-names>HJ</given-names></name>,
                <name><surname>Son</surname><given-names>SU</given-names></name>.
                <article-title>Microporous organic networks bearing metal-salen species for mild CO<sub>2</sub> fixation to cyclic carbonates</article-title>.
                <source>J Mater Chem A</source>.
                <year iso-8601-date="2013">2013</year>; 
                <volume>1</volume>: 
                <fpage>5517</fpage>-<lpage>5523</lpage>.
                </mixed-citation>
            </ref>
            <ref id="B-031">
                <label>31. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Marchetti</surname><given-names>F</given-names></name>,
                <name><surname>Tombesi</surname><given-names>A</given-names></name>,
                <name><surname>Di Nicola</surname><given-names>C</given-names></name>,
                <name><surname>Pettinari</surname><given-names>R</given-names></name>,
                <name><surname>Verdicchio</surname><given-names>F</given-names></name>,
                <name><surname>Crispini</surname><given-names>A</given-names></name>,
                <etal/>.
                <article-title>Zinc(II) Complex with pyrazolone-based hydrazones is strongly effective against Trypanosoma brucei which causes African sleeping sickness</article-title>.
                <source>Inorg Chem</source>.
                <year iso-8601-date="2022">2022</year>; 
                <volume>61</volume>: 
                <fpage>13561</fpage>-<lpage>13575</lpage>.
                </mixed-citation>
            </ref>
            <ref id="B-032">
                <label>32. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Gusev</surname><given-names>AN</given-names></name>,
                <name><surname>Shul'Gin</surname><given-names>VF</given-names></name>,
                <name><surname>Braga</surname><given-names>EV</given-names></name>,
                <name><surname>Nemec</surname><given-names>I</given-names></name>,
                <name><surname>Minaev</surname><given-names>BF</given-names></name>,
                <name><surname>Baryshnikov</surname><given-names>GV</given-names></name>,
                <etal/>.
                <article-title>Synthesis and photophysical properties of Zn(II) Schiff base complexes possessing strong solvent-dependent solid-state fluorescence</article-title>.
                <source>Polyhedron</source>.
                <year iso-8601-date="2018">2018</year>; 
                <volume>155</volume>: 
                <fpage>202</fpage>-<lpage>208</lpage>.
                </mixed-citation>
            </ref>
            <ref id="B-033">
                <label>33. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Baryshnikov</surname><given-names>GV</given-names></name>,
                <name><surname>Minaev</surname><given-names>BF</given-names></name>,
                <name><surname>Korop</surname><given-names>AA</given-names></name>,
                <name><surname>Minaeva</surname><given-names>VA</given-names></name>,
                <name><surname>Gusev</surname><given-names>AN</given-names></name>.
                <article-title>Structure of zinc complexes with 3-(pyridin-2-yl)-5-(arylideneiminophenyl)-1<italic>H</italic>-1,2,4-triazoles in different tautomeric forms: DFT and QTAIM study</article-title>.
                <source>Russ J Inorg Chem</source>.
                <year iso-8601-date="2013">2013</year>; 
                <volume>58</volume>: 
                <fpage>928</fpage>-<lpage>934</lpage>.
                </mixed-citation>
            </ref>
            <ref id="B-034">
                <label>34. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Gusev</surname><given-names>AN</given-names></name>,
                <name><surname>Kiskin</surname><given-names>MA</given-names></name>,
                <name><surname>Braga</surname><given-names>EV</given-names></name>,
                <name><surname>Kryukova</surname><given-names>MA</given-names></name>,
                <name><surname>Baryshnikov</surname><given-names>GV</given-names></name>,
                <name><surname>Karaush-Karmazin</surname><given-names>NN</given-names></name>,
                <etal/>.
                <article-title>Schiff base zinc(II) complexes as promising emitters for blue organic light-emitting diodes</article-title>.
                <source>ACS Appl Electron Mater</source>.
                <year iso-8601-date="2021">2021</year>; 
                <volume>3</volume>: 
                <fpage>3436</fpage>-<lpage>3444</lpage>.
                </mixed-citation>
            </ref>
            <ref id="B-035">
                <label>35. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Gusev</surname><given-names>A</given-names></name>,
                <name><surname>Braga</surname><given-names>E</given-names></name>,
                <name><surname>Zamnius</surname><given-names>E</given-names></name>,
                <name><surname>Kiskin</surname><given-names>M</given-names></name>,
                <name><surname>Kryukova</surname><given-names>M</given-names></name>,
                <name><surname>Baryshnikova A,et</surname><given-names>al</given-names></name>.
                <article-title>Structure and excitation-dependent emission of novel zinc complexes with pyridyltriazoles</article-title>.
                <source>RSC Adv</source>.
                <year iso-8601-date="2019">2019</year>; 
                <volume>9</volume>: 
                <fpage>22143</fpage>-<lpage>22152</lpage>.
                </mixed-citation>
            </ref>
            <ref id="B-036">
                <label>36. </label>
                <mixed-citation publication-type="other" publication-format="web">
                <article-title>WHO&#x2019;s World malaria report 2022</article-title> [Internet].
                <publisher-loc>Geneva</publisher-loc>:
                <publisher-name>WHO</publisher-name>;
                <year iso-8601-date="2022">2022</year>.
                <comment>Avaliable from: <ext-link  ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2022">https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2022</ext-link>.</comment>
                </mixed-citation>
            </ref>
            <ref id="B-037">
                <label>37. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Kumar</surname><given-names>B</given-names></name>,
                <name><surname>Devi</surname><given-names>J</given-names></name>,
                <name><surname>Dubey</surname><given-names>A</given-names></name>,
                <name><surname>Tufail</surname><given-names>A</given-names></name>,
                <name><surname>Sharma</surname><given-names>S</given-names></name>.
                <article-title>Exploring the antimalarial, antioxidant, anti-inflammatory activities of newly synthesized transition metal(II) complexes bearing thiosemicarbazone ligands: Insights from molecular docking, DFT, MESP and ADMET studies</article-title>.
                <source>Inorg Chem Commun</source>.
                <year iso-8601-date="2024">2024</year>; 
                <volume>159</volume>: 
                <fpage>111674</fpage>.
                </mixed-citation>
            </ref>
            <ref id="B-038">
                <label>38. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Ashley</surname><given-names>EA</given-names></name>,
                <name><surname>Phyo</surname><given-names>AP</given-names></name>.
                <article-title>Drugs in development for malaria</article-title>.
                <source>Drugs</source>.
                <year iso-8601-date="2018">2018</year>; 
                <volume>78</volume>: 
                <fpage>861</fpage>-<lpage>879</lpage>.
                </mixed-citation>
            </ref>
            <ref id="B-039">
                <label>39. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Tse</surname><given-names>EG</given-names></name>,
                <name><surname>Korsik</surname><given-names>M</given-names></name>,
                <name><surname>Todd</surname><given-names>MH</given-names></name>.
                <article-title>The past, present and future of anti-malarial medicines</article-title>.
                <source>Malar J</source>.
                <year iso-8601-date="2019">2019</year>; 
                <volume>18</volume>: 
                <fpage>93</fpage>.
                </mixed-citation>
            </ref>
            <ref id="B-040">
                <label>40. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Wells</surname><given-names>TN</given-names></name>,
                <name><surname>Burrows</surname><given-names>JN</given-names></name>,
                <name><surname>Baird</surname><given-names>JK</given-names></name>.
                <article-title>Targeting the hypnozoite reservoir of Plasmodium vivax: The hidden obstacle to malaria elimination</article-title>.
                <source>Trends Parasitol</source>.
                <year iso-8601-date="2010">2010</year>; 
                <volume>26</volume>: 
                <fpage>145</fpage>-<lpage>151</lpage>.
                </mixed-citation>
            </ref>
            <ref id="B-041">
                <label>41. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Luth</surname><given-names>MR</given-names></name>,
                <name><surname>Gupta</surname><given-names>P</given-names></name>,
                <name><surname>Ottilie</surname><given-names>S</given-names></name>,
                <name><surname>Winzeler</surname><given-names>EA</given-names></name>.
                <article-title>Using <italic>in vitro</italic> evolution and whole genome analysis to discover next generation targets for antimalarial drug discovery</article-title>.
                <source>ACS Infect Dis</source>.
                <year iso-8601-date="2018">2018</year>; 
                <volume>4</volume>: 
                <fpage>301</fpage>-<lpage>314</lpage>.
                </mixed-citation>
            </ref>
            <ref id="B-042">
                <label>42. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Hogg</surname><given-names>T</given-names></name>,
                <name><surname>Nagarajan</surname><given-names>K</given-names></name>,
                <name><surname>Herzberg</surname><given-names>S</given-names></name>,
                <name><surname>Chen</surname><given-names>L</given-names></name>,
                <name><surname>Shen</surname><given-names>X</given-names></name>,
                <name><surname>Jiang</surname><given-names>H</given-names></name>,
                <etal/>.
                <article-title>Structural and functional characterization of Falcipain-2, a hemoglobinase from the malarial parasite Plasmodium falciparum</article-title>.
                <source>J Biol Chem</source>.
                <year iso-8601-date="2006">2006</year>; 
                <volume>281</volume>: 
                <fpage>25425</fpage>-<lpage>25437</lpage>.
                </mixed-citation>
            </ref>
            <ref id="B-043">
                <label>43. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Kerr</surname><given-names>ID</given-names></name>,
                <name><surname>Lee</surname><given-names>JH</given-names></name>,
                <name><surname>Pandey</surname><given-names>KC</given-names></name>,
                <name><surname>Harrison</surname><given-names>A</given-names></name>,
                <name><surname>Sajid</surname><given-names>M</given-names></name>,
                <name><surname>Rosenthal</surname><given-names>PJ</given-names></name>,
                <etal/>.
                <article-title>Structures of falcipain-2 and falcipain-3 bound to small molecule inhibitors: Implications for substrate specificity</article-title>.
                <source>J Med Chem</source>.
                <year iso-8601-date="2009">2009</year>; 
                <volume>52</volume>: 
                <fpage>852</fpage>-<lpage>857</lpage>.
                </mixed-citation>
            </ref>
            <ref id="B-044">
                <label>44. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Ettari</surname><given-names>R</given-names></name>,
                <name><surname>Bova</surname><given-names>F</given-names></name>,
                <name><surname>Zappal&#x00E0;</surname><given-names>M</given-names></name>,
                <name><surname>Grasso</surname><given-names>S</given-names></name>,
                <name><surname>Micale</surname><given-names>N</given-names></name>.
                <article-title>Falcipain-2 inhibitors</article-title>.
                <source>Med Res Rev</source>.
                <year iso-8601-date="2010">2010</year>; 
                <volume>30</volume>: 
                <fpage>136</fpage>-<lpage>167</lpage>.
                </mixed-citation>
            </ref>
            <ref id="B-045">
                <label>45. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Teixeira</surname><given-names>C</given-names></name>,
                <name><surname>Rb Gomes</surname><given-names>J</given-names></name>,
                <name><surname>Gomes</surname><given-names>P</given-names></name>.
                <article-title>Falcipains, plasmodium falciparum cysteine proteases as key drug targets against malaria</article-title>.
                <source>Curr Med Chem</source>.
                <year iso-8601-date="2011">2011</year>; 
                <volume>18</volume>: 
                <fpage>1555</fpage>-<lpage>1572</lpage>.
                </mixed-citation>
            </ref>
            <ref id="B-046">
                <label>46. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Ettari</surname><given-names>R</given-names></name>,
                <name><surname>Previti</surname><given-names>S</given-names></name>,
                <name><surname>Di Chio</surname><given-names>C</given-names></name>,
                <name><surname>Zappal&#x00E0;</surname><given-names>M</given-names></name>.
                <article-title>Falcipain-2 and falcipain-3 inhibitors as promising antimalarial agents</article-title>.
                <source>Curr Med Chem</source>.
                <year iso-8601-date="2021">2021</year>; 
                <volume>28</volume>: 
                <fpage>3010</fpage>-<lpage>3031</lpage>.
                </mixed-citation>
            </ref>
            <ref id="B-047">
                <label>47. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Radha</surname><given-names>VP</given-names></name>,
                <name><surname>Chitra</surname><given-names>S</given-names></name>,
                <name><surname>Jonekirubavathi</surname><given-names>S</given-names></name>,
                <name><surname>Chung</surname><given-names>IM</given-names></name>,
                <name><surname>Kim</surname><given-names>SH</given-names></name>,
                <name><surname>Prabakaran</surname><given-names>M</given-names></name>.
                <article-title>Transition metal complexes of novel binuclear Schiff base derived from 3,3&#x2019;-diaminobenzidine: Synthesis, characterization, thermal behavior, DFT, antimicrobial and molecular docking studies</article-title>.
                <source>J Coord Chem</source>.
                <year iso-8601-date="2020">2020</year>; 
                <volume>73</volume>: 
                <fpage>1009</fpage>-<lpage>1027</lpage>.
                </mixed-citation>
            </ref>
            <ref id="B-048">
                <label>48. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Hubin</surname><given-names>TJ</given-names></name>,
                <name><surname>Amoyaw</surname><given-names>PN</given-names></name>,
                <name><surname>Roewe</surname><given-names>KD</given-names></name>,
                <name><surname>Simpson</surname><given-names>NC</given-names></name>,
                <name><surname>Maples</surname><given-names>RD</given-names></name>,
                <name><surname>Freeman</surname><given-names>TN</given-names></name>,
                <etal/>.
                <article-title>Synthesis and antimalarial activity of metal complexes of cross-bridged tetraazamacrocyclic ligands</article-title>.
                <source>Bioorg Med Chem</source>.
                <year iso-8601-date="2014">2014</year>; 
                <volume>22</volume>: 
                <fpage>3239</fpage>-<lpage>3244</lpage>.
                </mixed-citation>
            </ref>
            <ref id="B-049">
                <label>49. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Bagul</surname><given-names>AD</given-names></name>,
                <name><surname>Kumar</surname><given-names>M</given-names></name>,
                <name><surname>Alanazi</surname><given-names>AM</given-names></name>,
                <name><surname>Tufail</surname><given-names>A</given-names></name>,
                <name><surname>Tufail</surname><given-names>N</given-names></name>,
                <name><surname>Gaikwad</surname><given-names>DD</given-names></name>,
                <etal/>.
                <article-title>Experimental and computational evaluation of anti-malarial and antioxidant potential of transition metal (II) complexes with tridentate schiff base derived from pyrrolopyrimidine</article-title>.
                <source>BioMetals</source>.
                <year iso-8601-date="2024">2024</year>; 
                <volume>37</volume>: 
                <fpage>1713</fpage>-<lpage>1737</lpage>.
                </mixed-citation>
            </ref>
            <ref id="B-050">
                <label>50. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Sathvara</surname><given-names>JP</given-names></name>,
                <name><surname>Jadeja</surname><given-names>RN</given-names></name>,
                <name><surname>Butcher</surname><given-names>RJ</given-names></name>.
                <article-title>Synthesis, characterization, and crystal features of a mixed ligand binuclear Zinc(II) acyl pyrazolone complex: DFT, Hirshfeld surface analysis and anti-malarial activity evaluation</article-title>.
                <source>Inorg Chim Acta</source>.
                <year iso-8601-date="2024">2024</year>; 
                <volume>573</volume>: 
                <fpage>122316</fpage>.
                </mixed-citation>
            </ref>
            <ref id="B-051">
                <label>51. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Sathvara</surname><given-names>JP</given-names></name>,
                <name><surname>Butcher</surname><given-names>RJ</given-names></name>,
                <name><surname>Jadeja</surname><given-names>RN</given-names></name>.
                <article-title>Zinc(II) complexes of 4-acylhydrazone-5-pyrazolone: Synthesis, crystal structures, DFT, Hirshfeld analysis, and antimalarial potential</article-title>.
                <source>J Mol Struct</source>.
                <year iso-8601-date="2025">2025</year>; 
                <volume>1336</volume>: 
                <fpage>142071</fpage>.
                </mixed-citation>
            </ref>
            <ref id="B-052">
                <label>52. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Sathvara</surname><given-names>JP</given-names></name>,
                <name><surname>Butcher</surname><given-names>RJ</given-names></name>,
                <name><surname>Jadeja</surname><given-names>RN</given-names></name>.
                <article-title>Design, crystallography, characterization, Hirshfeld surface analysis, and antimalarial evaluation of a zinc(II) complex with 4-acylhydrazone-5-pyrazolone: A combined DFT and experimental approach</article-title>.
                <source>J Coord Chem</source>.
                <year iso-8601-date="2025">2025</year>; 
                <volume>78</volume>: 
                <fpage>1249</fpage>-<lpage>1271</lpage>.
                </mixed-citation>
            </ref>
            <ref id="B-053">
                <label>53. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Gusev</surname><given-names>A</given-names></name>,
                <name><surname>Shul'gin</surname><given-names>V</given-names></name>,
                <name><surname>Braga</surname><given-names>E</given-names></name>,
                <name><surname>Zamnius</surname><given-names>E</given-names></name>,
                <name><surname>Kryukova</surname><given-names>M</given-names></name>,
                <name><surname>Linert</surname><given-names>W</given-names></name>.
                <article-title>Luminescent properties of Zn complexes based on tetradentate N<sub>2</sub>O<sub>2</sub>-donor pyrazolone schiff bases</article-title>.
                <source>Dyes Pigments</source>.
                <year iso-8601-date="2020">2020</year>; 
                <volume>183</volume>: 
                <fpage>108626</fpage>.
                </mixed-citation>
            </ref>
            <ref id="B-054">
                <label>54. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Vladimirova</surname><given-names>KG</given-names></name>,
                <name><surname>Freidzon</surname><given-names>AY</given-names></name>,
                <name><surname>Kotova</surname><given-names>OV</given-names></name>,
                <name><surname>Vaschenko</surname><given-names>AA</given-names></name>,
                <name><surname>Lepnev</surname><given-names>LS</given-names></name>,
                <name><surname>Bagatur&#x2019;yants</surname><given-names>AA</given-names></name>,
                <etal/>.
                <article-title>Theoretical study of structure and electronic absorption spectra of some Schiff bases and their zinc complexes</article-title>.
                <source>Inorg Chem</source>.
                <year iso-8601-date="2009">2009</year>; 
                <volume>48</volume>: 
                <fpage>11123</fpage>-<lpage>11130</lpage>.
                </mixed-citation>
            </ref>
            <ref id="B-055">
                <label>55. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Diaz</surname><given-names>C</given-names></name>,
                <name><surname>Frazer</surname><given-names>A</given-names></name>,
                <name><surname>Morales</surname><given-names>A</given-names></name>,
                <name><surname>Belfield</surname><given-names>KD</given-names></name>,
                <name><surname>Ray</surname><given-names>S</given-names></name>,
                <name><surname>Hernandez</surname><given-names>FE</given-names></name>.
                <article-title>Structural identification of a novel axially chiral binaphthyl fluorene based salen ligand in solution using electronic circular dichroism: A theoretical&#x2013;experimental analysis</article-title>.
                <source>J Phys Chem A</source>.
                <year iso-8601-date="2012">2012</year>; 
                <volume>116</volume>: 
                <fpage>2453</fpage>-<lpage>2465</lpage>.
                </mixed-citation>
            </ref>
            <ref id="B-056">
                <label>56. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Sathvara</surname><given-names>JP</given-names></name>,
                <name><surname>Butcher</surname><given-names>RJ</given-names></name>,
                <name><surname>Jadeja</surname><given-names>RN</given-names></name>.
                <article-title>Salophen-type quadridentate zinc complexes from formyl pyrazolone: Synthesis, structure, DFT studies, fluorescence emission, and anti-malarial activity</article-title>.
                <source>J Mol Struct</source>.
                <year iso-8601-date="2025">2025</year>; 
                <volume>1348</volume>: 
                <fpage>143570</fpage>.
                </mixed-citation>
            </ref>
            <ref id="B-057">
                <label>57. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Misra</surname><given-names>M</given-names></name>,
                <name><surname>Pandey</surname><given-names>SK</given-names></name>,
                <name><surname>Pandey</surname><given-names>VP</given-names></name>,
                <name><surname>Pandey</surname><given-names>J</given-names></name>,
                <name><surname>Tripathi</surname><given-names>R</given-names></name>,
                <name><surname>Tripathi</surname><given-names>RP</given-names></name>.
                <article-title>Organocatalyzed highly atom economic one pot synthesis of tetrahydropyridines as antimalarials</article-title>.
                <source>Bioorg Med Chem</source>.
                <year iso-8601-date="2009">2009</year>; 
                <volume>17</volume>: 
                <fpage>625</fpage>-<lpage>633</lpage>.
                </mixed-citation>
            </ref>
            <ref id="B-058">
                <label>58. </label>
                <mixed-citation publication-type="journal">
                <name><surname>Bhalodiya</surname><given-names>SS</given-names></name>,
                <name><surname>Parmar</surname><given-names>MP</given-names></name>,
                <name><surname>Upadhyay</surname><given-names>DB</given-names></name>,
                <name><surname>Patel</surname><given-names>CD</given-names></name>,
                <name><surname>Vala</surname><given-names>DP</given-names></name>,
                <name><surname>Rajani</surname><given-names>D</given-names></name>,
                <etal/>.
                <article-title>Cs<sub>2</sub>CO<sub>3</sub>-promoted one-pot synthesis of novel tetrahydrobenzofuran-4(2<italic>H</italic>)-ones: <italic>In vitro</italic> antimicrobial, antimalarial activity and in silico docking study</article-title>.
                <source>Results Chem</source>.
                <year iso-8601-date="2024">2024</year>; 
                <volume>7</volume>: 
                <fpage>101304</fpage>.
                </mixed-citation>
            </ref>
        </ref-list>
    </back>
</article>